359
Participants
Start Date
July 2, 2024
Primary Completion Date
October 15, 2025
Study Completion Date
October 15, 2025
Site 156110 Beijing Jingmei Group Genetal Hospital, Beijing
Site 156125 - Nanjing Drum Tower Hospital, Nanjing
Site 156109 - Shandong Provincial Hospital, Jinan
Site 156103 - Shaoxing People's Hospital, Shaoxing
Site 156106 - Huzhou Central Hospital, Huzhou
Site 156112 - The First Affiliated Hospital of Ningbo University, Ningbo
Site 156123 - Wenling People's Hospital, Wenling
Site 156105 - Taizhou Central Hospital, Taizhou
Site 156115 - Jinhua Central Hospital, Jinhua
Site 156124 - Lishui People's Hospital, Lishui
Site 156108 - Henan Provincial People's Hospital, Zhengzhou
Site 156102 - Mianyang Central Hospital, Mianyang
Site 156101 - The First Affiliated Hospital of Guangzhou Medical University, Guangzhou
Site 156113 - The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou
Site 156114 - The Second Affiliated Hospital of Guangdong Medical University, Zhanjiang
Site 156122 - Deyang People's Hospital, Deyang
Site 156117 - The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an
Site 156121 - The First Affiliated Hospital of Xinjiang Medical University, Ürümqi
Chiesi Farmaceutici S.p.A.
INDUSTRY